Prokidney Corp Stock Price Prediction

PROK Stock  USD 1.69  0.05  2.87%   
The RSI of ProKidney Corp's the stock price is about 64 indicating that the stock is rather overbought by investors as of now. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling ProKidney, making its price go up or down.

Oversold Vs Overbought

64

 
Oversold
 
Overbought
The successful prediction of ProKidney Corp's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with ProKidney Corp, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting ProKidney Corp's stock price prediction:
EPS Estimate Next Quarter
(0.14)
EPS Estimate Current Year
(0.58)
EPS Estimate Next Year
(0.60)
Wall Street Target Price
4.6667
EPS Estimate Current Quarter
(0.15)
Using ProKidney Corp hype-based prediction, you can estimate the value of ProKidney Corp from the perspective of ProKidney Corp response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ProKidney Corp to buy its stock at a price that has no basis in reality. In that case, they are not buying ProKidney because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

ProKidney Corp after-hype prediction price

    
  USD 1.67  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out ProKidney Corp Basic Forecasting Models to cross-verify your projections.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.
Intrinsic
Valuation
LowRealHigh
0.255.0611.15
Details
Naive
Forecast
LowNextHigh
0.031.597.68
Details
8 Analysts
Consensus
LowTargetHigh
13.9515.3317.02
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.15-0.14-0.14
Details

ProKidney Corp After-Hype Price Prediction Density Analysis

As far as predicting the price of ProKidney Corp at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ProKidney Corp or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ProKidney Corp, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

ProKidney Corp Estimiated After-Hype Price Volatility

In the context of predicting ProKidney Corp's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ProKidney Corp's historical news coverage. ProKidney Corp's after-hype downside and upside margins for the prediction period are 0.08 and 7.76, respectively. We have considered ProKidney Corp's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.69
1.67
After-hype Price
7.76
Upside
ProKidney Corp is unstable at this time. Analysis and calculation of next after-hype price of ProKidney Corp is based on 3 months time horizon.

ProKidney Corp Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as ProKidney Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ProKidney Corp backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ProKidney Corp, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.23 
6.09
  0.02 
  0.01 
9 Events / Month
18 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.69
1.67
1.18 
6,767  
Notes

ProKidney Corp Hype Timeline

ProKidney Corp is at this time traded for 1.69. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.01. ProKidney is estimated to decline in value after the next headline, with the price expected to drop to 1.67. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.18%, whereas the daily expected return is at this time at -0.23%. The volatility of related hype on ProKidney Corp is about 10227.48%, with the expected price after the next announcement by competition of 1.70. About 27.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.54. ProKidney Corp had not issued any dividends in recent years. The entity had 1:1 split on the 12th of July 2022. Given the investment horizon of 90 days the next estimated press release will be in about 9 days.
Check out ProKidney Corp Basic Forecasting Models to cross-verify your projections.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

ProKidney Corp Related Hype Analysis

Having access to credible news sources related to ProKidney Corp's direct competition is more important than ever and may enhance your ability to predict ProKidney Corp's future price movements. Getting to know how ProKidney Corp's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ProKidney Corp may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RLAYRelay Therapeutics(0.20)11 per month 0.00 (0.06) 4.82 (6.29) 66.18 
STOKStoke Therapeutics 0.46 10 per month 0.00 (0.09) 4.68 (6.99) 21.35 
PLRXPliant Therapeutics 0.22 9 per month 3.19 (0.02) 5.37 (5.55) 24.35 
BDTXBlack Diamond Therapeutics 0.18 7 per month 0.00 (0.30) 5.56 (8.30) 19.51 
ARVNArvinas(0.04)8 per month 3.43  0  4.85 (5.50) 17.13 
ACLXArcellx 6.42 10 per month 2.74  0.12  6.28 (5.68) 15.13 
VTYXVentyx Biosciences(0.02)7 per month 0.00 (0.03) 6.94 (5.86) 22.25 
IMCRImmunocore Holdings 2.04 10 per month 0.00 (0.1) 3.54 (4.18) 10.78 
PCVXVaxcyte(10.51)10 per month 2.19  0.03  3.16 (4.09) 42.81 
DICEDice Molecules Holdings 0.02 7 per month 1.14  0.10  5.66 (2.91) 37.64 
THRDThird Harmonic Bio 0.47 7 per month 4.92  0.01  8.91 (6.74) 25.76 
PMVPPmv Pharmaceuticals(0.1)3 per month 2.01 (0.01) 3.75 (3.64) 13.98 
EWTXEdgewise Therapeutics 0.32 10 per month 2.85  0.11  6.65 (4.70) 61.02 
RVMDRevolution Medicines 1.13 10 per month 2.04  0.12  4.81 (3.24) 10.95 
KURAKura Oncology(0.02)10 per month 0.00 (0.17) 4.98 (4.04) 42.52 
PTGXProtagonist Therapeutics 0.18 10 per month 2.23  0.03  3.70 (3.74) 14.61 
MRUSMerus BV 1.06 7 per month 0.00 (0.17) 3.08 (2.83) 10.85 
REPLReplimune Group(0.10)6 per month 2.86  0.11  7.38 (5.60) 15.63 
CERECerevel Therapeutics Holdings 0.20 9 per month 0.94 (0.04) 1.91 (1.59) 6.40 
GLUEMonte Rosa Therapeutics(0.25)9 per month 3.86  0.08  10.11 (8.18) 102.66 
ERASErasca Inc(0.08)8 per month 3.67 (0.02) 7.34 (5.38) 17.38 
LYELLyell Immunopharma(0.07)7 per month 0.00 (0.07) 13.39 (9.47) 36.92 

ProKidney Corp Additional Predictive Modules

Most predictive techniques to examine ProKidney price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ProKidney using various technical indicators. When you analyze ProKidney charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About ProKidney Corp Predictive Indicators

The successful prediction of ProKidney Corp stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ProKidney Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ProKidney Corp based on analysis of ProKidney Corp hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ProKidney Corp's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ProKidney Corp's related companies.
 2021 2022 2023 (projected)
Net Debt To EBITDA0.363.390.38
Intangibles To Total Assets0.01064.11E-44.73E-4

Story Coverage note for ProKidney Corp

The number of cover stories for ProKidney Corp depends on current market conditions and ProKidney Corp's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ProKidney Corp is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ProKidney Corp's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

ProKidney Corp Short Properties

ProKidney Corp's future price predictability will typically decrease when ProKidney Corp's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ProKidney Corp often depends not only on the future outlook of the potential ProKidney Corp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ProKidney Corp's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding61.7 M
Cash And Short Term Investments362.9 M
When determining whether ProKidney Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ProKidney Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Prokidney Corp Stock. Highlighted below are key reports to facilitate an investment decision about Prokidney Corp Stock:
Check out ProKidney Corp Basic Forecasting Models to cross-verify your projections.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Return On Assets
(0.20)
Return On Equity
(0.31)
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.